Nuwellis (NUWE) said via X, the platform formerly known as Twitter, on Wednesday night, that as of January 1, 2025, the CMS reimbursement for Aquadex just “quadrupled” under APC 5242, “making it a game-changer for outpatient care!” Shares of Nuwellis are up 20% in early trading to $1.35.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUWE: